| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/18/2001 | WO2001004635A1 Rapid test employing an adhesive slide |
| 01/18/2001 | WO2001004631A1 A sensor comprising a hydrophilic matrix material |
| 01/18/2001 | WO2001004629A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
| 01/18/2001 | WO2001004626A1 An electrochemical method for enrichment of microorganism, a biosensor for analyzing organic substance and bod |
| 01/18/2001 | WO2001004618A1 Increased throughput analysis of small compounds using multiple temporally spaced injections |
| 01/18/2001 | WO2001004614A1 Electrochemical biosensor using silver silver chloride electrode and chromatography matrix |
| 01/18/2001 | WO2001004613A1 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 01/18/2001 | WO2001004361A2 Detection of hiv-1 by nucleic acid amplification |
| 01/18/2001 | WO2001004360A2 Retroviral recombination assays and uses thereof |
| 01/18/2001 | WO2001004359A1 Prophage dna sequences and their use in determining instability in lactobacilli cultures |
| 01/18/2001 | WO2001004358A2 Detection of anti-hepatitis b drug resistance |
| 01/18/2001 | WO2001004357A2 Generic sbe-fret protocol |
| 01/18/2001 | WO2001004356A1 Modulation of egr-1 and egr-2 in heart disease |
| 01/18/2001 | WO2001004355A1 A method for sequencing long-length dna |
| 01/18/2001 | WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy |
| 01/18/2001 | WO2001004353A1 Methods of diagnosing cancer by detecting abnormality in chromosome |
| 01/18/2001 | WO2001004352A2 Dna polymorphisms in sterol regulator element binding proteins |
| 01/18/2001 | WO2001004351A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 01/18/2001 | WO2001004350A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | WO2001004349A2 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
| 01/18/2001 | WO2001004348A1 Methods to identify inhibitors of f1/f0 atpase |
| 01/18/2001 | WO2001004347A1 Method to identify inhibitors f1/f0 atpase |
| 01/18/2001 | WO2001004346A1 Method to identify antimicrobial agents |
| 01/18/2001 | WO2001004345A1 Method of differentiating between bacterial and viral infections |
| 01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
| 01/18/2001 | WO2001004343A2 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004325A1 Nucleotide sequences for the tal gene |
| 01/18/2001 | WO2001004322A1 Nucleotide sequences which code for the opca gene |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004291A1 Non-lactate-assimilating yeast for improving aerobic stability of silage |
| 01/18/2001 | WO2001004288A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004272A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/18/2001 | WO2001004270A1 Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene |
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
| 01/18/2001 | WO2001004153A1 Death effector domain of mammalian apoptosis mediator, fadd, inducing bacterial cell death |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004137A1 Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001003743A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003692A1 Compositions and methods for promoting nerve regeneration |
| 01/18/2001 | WO2001003686A2 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 01/18/2001 | WO2001003573A2 Method of diagnosis of cardiac hypertrophy |
| 01/18/2001 | WO2000071670A3 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000061720A3 Allele-specific strand displacement amplification primers and method |
| 01/18/2001 | WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000053794A3 Trait-associated gene identification method |
| 01/18/2001 | WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
| 01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO1999064620A3 Diagnostic assay requiring a small sample of biological fluid |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | WO1999051756A3 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 01/18/2001 | DE19934084A1 Labeling DNA fragments during polymerase chain reaction, useful e.g. for sequencing or polymorphic analysis, uses labeled universal primer and sequence-specific primers |
| 01/18/2001 | DE19933237A1 Verfahren zur Bestimmung der Proliferationsaktivität von Zellen A method for determining the proliferative activity of cells |
| 01/18/2001 | DE19853185C1 Exponential amplification of molecular matrices, useful for chemical evolution of e.g. peptides or nucleic acids, by synthesizing copies of immobilized matrices |
| 01/18/2001 | DE19822827A1 Verfahren zur Durchführung einer Messung der Interaktion von Chemikalien mit Zellen A method for performing a measurement of the interaction of chemicals with cells |
| 01/18/2001 | DE10020885A1 Preparation of a chemo- and thermo-stabile solid phase matrix for combining a polymerase chain reaction and a hybridization assay, by reacting a biotinylated cross-linking agent with a carrier material in strong basic or acid buffer |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2779554A1 Compositions and kits for detection of hiv-1 by nucleic acid amplification |
| 01/18/2001 | CA2380339A1 Method of diagnosis of cardiac hypertrophy |
| 01/18/2001 | CA2379345A1 T-cell receptor .gamma. alternate reading frame protein, (tarp) and uses thereof |
| 01/18/2001 | CA2379264A1 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
| 01/18/2001 | CA2379207A1 Retroviral recombination assays and uses thereof |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2379119A1 Method to identify inhibitors f1/f0 atpase |
| 01/18/2001 | CA2379118A1 Method to identify antimicrobial agents |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378982A1 Methods of inhibiting muscle atrophy |
| 01/18/2001 | CA2378921A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378665A1 Dna polymorphisms in sterol regulator element binding proteins |
| 01/18/2001 | CA2378616A1 Genetic testing |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378580A1 An electrochemical method for enrichment of microorganism, a biosensor for analyzing organic substance and bod |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378515A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | CA2378509A1 Rapid test employing an adhesive slide |
| 01/18/2001 | CA2378465A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | CA2378433A1 Prophage dna sequences and their use in determining instability in lactobacilli cultures |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |